Interestingly, this study confirmed that PLCβ1 gene expression was significantly reduced in all WHO IV gliomas (glioblastoma), not only in specific subtypes, compared to WHO II and WHO III gliomas, suggesting a strongly pathological role of PLCβ1 low expression. Here, PLCB1 is linked to glioma.